The National Medicines Agency (EOF) announces that the product Cardiotensive is being promoted via the internet.

Cardiotensive, advertised with therapeutic indications (normalization of blood pressure, treatment of vein thrombosis, treatment of arrhythmia), without having a marketing authorization. Therefore, its safety and efficacy have not been evaluated.

It is pointed out that on the websites through which the above product is promoted, it is misleadingly displayed with “spectacular” results, while the consumer is asked to send a completed contact form, without knowing the full details of the company responsible for its circulation.

The attention of consumers is drawn so that in the event that the above product comes into their possession, they do not use it and inform the EOF immediately.

It is pointed out that the purchase of EOF products from non-approved sources, such as online stores, may endanger the health of the consumer, as the quality and safety of the products are not guaranteed.